Posted inWire
The US Oncology Network finds cancer drug may benefit advanced COVID-19 patients
HOUSTON: Rapid improvements have been seen in acutely ill patients with COVID-19 treated with the cancer drug acalabrutinib (Calquence) by researchers, including physicians within The US Oncology Network. Results of…